Con il tuo consenso utilizziamo analisi limitate e rispettose della privacy per capire quali percorsi di ricerca funzionano. Non usiamo tracker pubblicitari né registrazioni delle sessioni. Puoi modificare questa scelta nelle Preferenze. Leggi la Informativa sulla privacy.
Quote this valuation with its source: Fair value, Potential value and the price at analysis.
FAQ
CLX — frequently asked questions
Is The Clorox Company overvalued?
In our latest published analysis dated 2026-09-20, CLX looks meaningfully undervalued. The price recorded at analysis is 83,1 USD versus our fair value of 105 USD; the high endpoint is presented separately as potential value of 186 USD. That implies roughly 26.1% upside to fair value at that date.
Our latest published report, analyzed 2026-09-20, gives CLX a fair value of 105 USD and a potential value of 186 USD. The conclusion is triangulated across multiple valuation models and weighted by reliability for The Clorox Company's archetype; it is a dated research output, not a live price.
Should I buy CLX now?
Our latest published rating for CLX, analyzed 2026-09-20, is Buy. The Clorox Company looks meaningfully undervalued at the analysis-date price of 83,1 USD versus fair value of 105 USD; potential value is 186 USD. This is research for educational purposes, not personalized investment advice.
What are the biggest risks for CLX?
The dedicated bear-case section in our report analyzed 2026-09-20 documents The Clorox Company's material risks, evidence, thresholds, and thesis-invalidation conditions. Scenario-specific explanations remain in that section so the report does not repeat or decontextualize them elsewhere.
What is CLX's rating?
Our latest published rating for CLX, analyzed 2026-09-20, is Buy, with a published moat assessment of 6.5/10 (Narrow). It reflects our fair value of 105 USD, the potential value of 186 USD, and the price recorded at analysis (83,1 USD).
Questo report non è ancora stato tradotto. Aggiorna tra qualche minuto una volta che la coda di traduzione avrà recuperato.
§1 SintesiEN
Risposta in 30 secondiBuy
Prezzo rispetto al valore
Prezzo
$83.10
Fair value
$104.80
Valore potenziale
$185.52
Al
2026-09-18
Perché può funzionare
Restoring retail distribution breadth and consumer volume following supply disruptions drives fiscal 2027 net sales toward consensus estimates of $7,630M, enabling fixed-cost absorption to lift operating margins toward the 18.80% industry benchmark and advancing equity value toward Fair value of $104.80.
Cosa cambierebbe la nostra valutazione
Reported fiscal 2027 net sales growth falls below 8.0% YoY over the next 12 months.
Clorox is rated a Buy as retail distribution recovery offers 26.1% upside to our Fair value of $104.80, balanced against elevated debt of $5,520M.4
We rate The Clorox Company a Buy, indicating that the shares offer an attractive entry point for investors seeking operational recovery.
On September 18, 2026, the report was prepared with the stock at $83.10. This price stands 26.1% below our Fair value of $104.80, with long-term potential reaching $185.52 if turnaround execution accelerates.4
The primary risk is that retail shelf-space recovery fails if store brands permanently displace Clorox products. If fiscal 2027 sales growth stalls below 8.0%, operating cash flow will drop, making it difficult to service $5,520M in debt.
The main reason the stock can outperform is that brand equity supports retail distribution replenishment. Rebuilding retail shipments is expected to lift sales toward $7,630M in fiscal 2027, restoring operating cash flow above $612M and driving per-share value toward Fair value.1,4
Rebuilding retail shipments after supply disruptions is projected to restore fiscal 2027 revenue by 13.55% to $7,630M.1,4
Defensive Brand Equity
A 42.32% gross profit margin reflects durable consumer brand pricing power above household peer averages.4
Raccomandazione interna
Buy: operational distribution recovery supports cash generation toward Fair value of $104.80, offsetting risks from elevated leverage and competitor promotions.4
Panoramica dell’azienda
The Company operates through strategic business units (SBUs) which are organized into operating segments. Operating segments are then aggregated into four reportable segments: Health and Wellness, Household, Lifestyle and International. The Company's IGNITE strategy accelerates innovation in key areas of the business to drive growth and deliver value for all Company stakeholders. IGNITE focuses on four strategic choices aimed at fueling long-term, profitable growth; innovating consumer experiences; reimagining how the company and its people work; and continuously evolving the product portfolio. In addition, IGNITE's integrated approach to sustainability supports long-term value creation for the Company and its stakeholders.
•Health and Wellness consists of cleaning, disinfecting, sanitizing and professional products marketed and sold in the United States.
§2 Scenario ribassistaEN
In a severe operational stress test where volume restoration stalls and promotional concessions compress operating margins toward 12.0%, free cash flow drops below debt service requirements. With $5,520M in total debt and $602M in annual dividend commitments, post-dividend cash flow turns deeply negative, forcing credit rating downgrades and debt refinancing at elevated borrowing costs.
Competitive promotions and private label penetration restrict volume recovery, forcing retailer concessions that impair cash flow and elevate balance sheet refinancing strain.
Come questa tesi può fallire
Turnaround Volume Restoration Failure
Retailers decline to restore pre-outage shelf space and private label substitution permanently displaces Clorox products, causing FY27 revenue rebound to miss minimum recovery threshold of 8.0% YoY.4
FV impact
-2.1%
Revenue and EPS growth 5 points lower for five years
Trigger
Within 12 months
Promotional Margin Collapse
Price wars and retailer concessions to defend volume against peers compress operating margin below 12.0%.
Segnali di allerta precoce da monitorare
I cinque sviluppi che indebolirebbero la nostra tesi d'investimento.
01
Annual Net Sales Growth
Failure to rebound indicates permanent retail shelf-space loss to private label brands following distribution disruptions, impairing top-line recovery and fixed-cost absorption across domestic manufacturing facilities.
Clorox possesses a Narrow economic moat grounded in brand intangible assets and scale distribution advantages across household cleaning categories. Its flagship brand commands consumer recognition, allowing the company to sustain a 42.32% gross margin, which exceeds peer averages such as Kimberly-Clark at 37.61%.
However, moat breadth remains narrow rather than wide due to intense competition from branded peers like Church & Dwight (operating margin 18.07%) and retail private label substitution. These competitive pressures constrain long-term pricing leverage and necessitate ongoing promotional spending to maintain retail shelf space.
Profitto economico
Clorox generates economic profits through brand equity in domestic cleaning that commands consumer loyalty, though peer rivalry from Church & Dwight and Kimberly-Clark limits pricing power.
02Scale Distribution Cost Advantage — Scale distribution relationships across primary retail channels enable nationwide fulfillment and shelf presence across domestic cleaning aisles.
The highlighted cell is Fair value when every assumption sits at its base level ($104.80). Each row and column shows what Fair value becomes when one assumption moves.
FY2026 operating cash flow reached $612M with capital expenditures disciplined at $207M, generating $405M in free cash flow. However, annual dividend distributions of $602M exceed free cash flow, creating negative net cash after dividends and restricting organic debt reduction.4,5
Allocazione del capitale
Management curtailed share repurchases, recording negative buyback outflows of $256M in FY2026, while prioritizing dividend continuity and debt service on $5,520M in total debt.
Ricavi più recenti6,7 Mld USDCAGR dei ricavi +1,3%
Margine operativo24,7%10 periodi fiscali
Flusso di cassa libero più recente405 Mln USDFY2026
Debito netto5,4 Mld USDFY2026
Dettaglio del conto economicoCome la scala aziendale si traduce in utile dichiarato.
StockMarketAgent.AI
Ricavi6,7 Mld USDCosto del venduto−3,9 Mld USDUtile lordo2,8 Mld USDCosti operativi−1,2 Mld USDReddito operativo1,7 Mld USDVoci non operative e imposte−1,1 Mld USDUtile netto587 Mln USD
Dati della storia finanziaria
Ricavi
6.720.000.000 USD
Costo del venduto
3.876.000.000 USD
Utile lordo
2.844.000.000 USD
Costi operativi
1.182.000.000 USD
Reddito operativo
1.662.000.000 USD
Voci non operative e imposte
-1.075.000.000 USD
Utile netto
587.000.000 USD
Panoramica dello stato patrimonialeCome sono detenute e finanziate le attività dichiarate nel periodo selezionato.
StockMarketAgent.AI
Composizione delle attivitàFinanziato da
Attività totali7,8 Mld USDDisponibilità liquide143 Mln USDAttività correnti1,8 Mld USDPassività totali7,5 Mld USDPassività correnti2,8 Mld USDPatrimonio netto252 Mln USD
Dati di dettaglio dello stato patrimoniale
Attività totali
7.794.000.000 USD
Disponibilità liquide
143.000.000 USD
Attività correnti
1.824.000.000 USD
Passività totali
7.542.000.000 USD
Passività correnti
2.773.000.000 USD
Patrimonio netto
252.000.000 USD
Ponte dei flussi di cassaCome il flusso di cassa operativo è diventato flusso di cassa libero nel FY2026.
StockMarketAgent.AI
Riconciliazione del flusso operativo
Utile netto587 Mln USDAmmortamenti e svalutazioni+247 Mln USDCompensi basati su azioni+48 Mln USDAltre rettifiche operative−270 Mln USDFlusso di cassa operativo612 Mln USD
Riconciliazione della liquidità iniziale e finale
Liquidità iniziale170 Mln USDFlusso di cassa operativo+612 Mln USDFlusso da investimenti−2,3 Mld USDFlusso da finanziamenti+1,7 Mld USDEffetto dei tassi di cambio−2 Mln USDLiquidità finale143 Mln USD
612 Mln USD − 207 Mln USDFlusso di cassa libero 405 Mln USD
Dati del ponte dei flussi di cassa
Utile netto
587.000.000 USD
Afflusso operativo
882.000.000 USD
Ammortamenti e svalutazioni
247.000.000 USD
Compensi basati su azioni
48.000.000 USD
Flusso di cassa operativo
612.000.000 USD
Deflusso operativo
270.000.000 USD
Liquidità disponibile
2.450.000.000 USD
Liquidità iniziale
170.000.000 USD
Afflusso da finanziamenti
1.668.000.000 USD
Deflusso da investimenti
2.301.000.000 USD
Capex
207.000.000 USD
Altre attività di investimento
2.094.000.000 USD
Effetto dei tassi di cambio
2.000.000 USD
Liquidità finale
143.000.000 USD
Flusso da investimenti
-2.301.000.000 USD
Flusso da finanziamenti
1.668.000.000 USD
Ricavi e utiliCome la scala aziendale si traduce in utile dichiarato.
Liquidità e debitoLiquidità disponibile rispetto all’indebitamento totale.
Generazione di cassaFlusso di cassa operativo rispetto al flusso di cassa libero.
RedditivitàEvoluzione dei margini lordo, operativo e netto.
Dati finanziari puntuali utilizzati nell’analisi del 2026-09-20.
The Clorox Company (CLX) trades at 14.2x forward earnings against a peer median of 18.3x. Its EV/EBITDA of 13.7x compares with a peer median of 13.5x. The comparison uses 4 peers: The J.M. Smucker Company, Church & Dwight Co. Inc., Kimberly-Clark Corporation and The Estee Lauder Companies Inc., as of 2026-09-20.
§10 Settore e cicloEN
Fase del ciclo
Contraction
Industry capital expenditures to depreciation stand at 1.07 and capex to revenue is 1.1%, reflecting disciplined maintenance spending rather than aggressive manufacturing capacity additions across consumer defensive peers.
Ciclo rialzista
Demand expansion accelerates as consumer staple volume recovers across retail grocery channels, enabling branded producers to protect gross margins above 45%.
Ciclo ribassista
Persistent consumer trade-down to private label forces defensive promotional concessions, keeping operating margins near 13.7% and limiting organic growth.
E-Commerce and Omnichannel Household Replenishment
positive
Subscription delivery models and digital re-ordering favor established national brands with high customer loyalty.
Post-Pandemic Health and Disinfection Habits
positive
Sustained household and institutional sanitation standards maintain baseline demand for core cleaning products.
Posizionamento
Clorox maintains leading market share in domestic bleach and cleaning categories, but must balance trade promotions against peers Church & Dwight and Kimberly-Clark while repairing supply chain relationships.
§11 Gestione della posizioneEN
Dimensionamento
3-5%
Moderate position sizing reflects operational turnaround execution potential balanced against elevated leverage of $5,520M debt.4
Rischio
Portfolio risk is managed through disciplined stop-loss execution and position sizing caps to insulate capital against leverage and competitive headwinds.
Tranche di ingresso
Livello
Azione
Perché
$83.10
Initiate primary tranche
Report-date price of $83.10 offers a 26.1% discount to Fair value of $104.80.
$78.00-$80.00
Add secondary tranche
Provides enhanced margin of safety if broader market volatility compresses consumer defensive multiples.
The shares trade at a 26.1% discount to Fair value of $104.80, supported by $612M in operating cash flow and resilient brand equity.4
Turnaround Operational Perspective
Buy
Shipment recovery across retail partners is projected to lift fiscal 2027 revenue by 13.55% to $7,630M, driving operational normalization.1
Balance Sheet and Income Perspective
Buy
Maintain a disciplined 3% to 5% allocation while monitoring debt service on $5,520M debt against operating cash generation.4
§14 Raccomandazione finaleEN
Azione
Comprare
We recommend a Buy on The Clorox Company based on operational recovery restoring distribution and driving revenue toward $7,630M in fiscal 2027.1
At $83.10, the stock trades at an attractive 26.1% discount to Fair value of $104.80, with robust underlying cash conversion of $612M operating cash flow supporting debt service.
§15Your notes
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
Private notes
Visible only to you. Synced to this device.
0 chars
Sources
The records this analysis drew on, as they stood when it was run.
Market and peer researchData as of 2026-09-20 · Published 2026-09-20 · Provider-adjusted · cited for 2 figuresCited in Moat competitivo, Settore e ciclo
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
Inability to deleverage against $5,520M total debt forces refinancing at wider credit spreads, elevating borrowing costs and pushing cost of capital above 8.58%.2,4
Intense promotional concessions to defend market share against Church & Dwight erode core profitability, reducing operating earnings and preventing the business from funding necessary marketing reinvestment.
Diminished cash generation leaves insufficient liquidity to cover capital expenditures and dividend commitments, stalling debt paydown and forcing reliance on additional external borrowing.
Persistent commodity input inflation combined with unrecovered retail pricing power compresses product margins, demonstrating that branded equity is failing to command consumer price premiums over private store alternatives.
Turnaround execution outpaces expectations as consumer loyalty drives retail shelf replenishment and margin expansion toward Potential value of $185.52.
Perché è importante
Margin expansion toward peer levels demonstrates brand pricing power and promotional discipline.
